HETEROARYL PIPERIDINE GLYCINE TRANSPORTER INHIBITORS

The present invention is directed to pyridyl, pyridazinyl, pyrimidinyl and pyrazinyl piperidine compounds that inhibit the glycine transporter GlyT1 and which are useful in the treatment of neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunct...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LEWIS, RICHARD, T, LINDSLEY, CRAIG, W, DUGGAN, MARK, E, WANG, YI, HALLETT, DAVID, BLACKABY, WESLEY, WOLKENBERG, SCOTT, E, LEISTER, WILLIAM, H, NAYLOR, ELIZABETH, HARTMAN, GEORGE, D, WISNOSKI, DAVID, D, JENNINGS, ANDREW, S, ZHAO, ZHIJIAN, STREET, LESLIE, J
Format:	Patent
Sprache:	eng ; fre
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention is directed to pyridyl, pyridazinyl, pyrimidinyl and pyrazinyl piperidine compounds that inhibit the glycine transporter GlyT1 and which are useful in the treatment of neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction and diseases in which the glycine transporter GlyT1 is involved. La présente invention concerne des composés de pyridyle, pyridazinyle, pyrimidinyle et pyrazinylpipéridine, inhibant le transporteur de glycine GlyT1 et utiles dans le traitement de troubles neurologiques et psychiatriques associés au dysfonctionnement de la neurotransmission glycinergique ou glutamatergique et de maladies dans lesquelles le transporteur de glycine GlyT1 est impliqué.